Literature DB >> 9578257

Recurrent pleomorphic adenomas of the parotid gland: clinical evaluation and long-term follow-up.

R Laskawi1, T Schott, M Schröder.   

Abstract

We report 94 patients with recurrent pleomorphic adenomas of the parotid gland who were referred to our clinics after operations elsewhere. In 78 patients (83%) enucleation was the surgical technique used to remove the tumour. Patients with more than one recurrence were significantly younger than patients who had only one. Many recurrent adenomas (44%) were multifocal. In 20 (21%) further recurrences became obvious after we had operated on them. The mean time interval before recurrence ranged from 7.3 to 10.1 years. Twenty patients (14%) had persistent motor disorders of the facial nerve after operation for recurrence (n = 143). Twenty eight of the 84 patients from whom follow-up data could be obtained developed Frey's syndrome (33%). Our data support the importance of an adequate initial operation to avoid recurrences of pleomorphic adenomas in the parotid gland.

Entities:  

Mesh:

Year:  1998        PMID: 9578257     DOI: 10.1016/s0266-4356(98)90748-3

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  13 in total

1.  Multinodular neck recurrence of parotid gland pleomorphic adenoma: a case report.

Authors:  Nick Papadogeorgakis; Evagelos F Kalfarentzos; Vassilis Petsinis; Eleni Parara; Maria-Emmanouela Kopaka
Journal:  Oral Maxillofac Surg       Date:  2011-06-10

2.  Metastatic pleomorphic adenoma to the supraspinatus muscle: a case report and review of a rare aggressive clinical entity.

Authors:  James G McGarry; Maeve Redmond; John B Tuffy; Lorraine Wilson; Seamus Looby
Journal:  J Radiol Case Rep       Date:  2015-10-31

Review 3.  Diseases of the salivary glands in infants and adolescents.

Authors:  Maik Ellies; Rainer Laskawi
Journal:  Head Face Med       Date:  2010-02-15       Impact factor: 2.151

Review 4.  [Skin adnexal and salivary gland neoplasms. Similarities and differences of selected patients].

Authors:  T Mentzel
Journal:  Pathologe       Date:  2004-02       Impact factor: 1.011

5.  Pleomorphic adenoma of the submandibular gland: an evolving change in practice following review of a personal case series.

Authors:  Nazia Munir; Patrick J Bradley
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-07-05       Impact factor: 2.503

6.  PLAG1 expression is maintained in recurrent pleomorphic adenoma.

Authors:  Beatriz Samara de Brito; Natália Giovanelli Gaspar; Erika Said Abu Egal; Celeste Sanchez-Romero; Antonio Santos Martins; Álfio José Tincani; Rogério de Oliveira Gondak; Oslei Paes de Almeida; Luiz Paulo Kowalski; Albina Altemani; Fernanda Viviane Mariano
Journal:  Virchows Arch       Date:  2016-07-06       Impact factor: 4.064

7.  [Radiotherapy : an option for refractory salivary fistulas].

Authors:  H Christiansen; H A Wolff; J Knauth; A Hille; H Vorwerk; C Engelke; R Rödel; R Laskawi
Journal:  HNO       Date:  2009-12       Impact factor: 1.284

8.  Tumor-initiating cells are enriched in CD44(hi) population in murine salivary gland tumor.

Authors:  Shukun Shen; Wenjun Yang; Zhugang Wang; Xia Lei; Liqun Xu; Yang Wang; Lizhen Wang; Lei Huang; Zhiwei Yu; Xinhong Zhang; Jiang Li; Yan Chen; Xiaoping Zhao; Xuelai Yin; Chenping Zhang
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

9.  Mena, a new available marker in tumors of salivary glands?

Authors:  S Gurzu; M Krause; I Ember; L Azamfirei; G Gobel; K Feher; I Jung
Journal:  Eur J Histochem       Date:  2012-02-07       Impact factor: 3.188

10.  Clinical manifestations of recurrent parotid pleomorphic adenoma.

Authors:  Myung-Whan Suh; J Hun Hah; Seong Keun Kwon; Young-Ho Jung; Tack-Kyun Kwon; Kwang Hyun Kim; Myung-Whun Sung
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-12-31       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.